Michael J. Akers

1.6k citations
50 papers · 1.2k indexed · h-index 16
Topics
Drug Solubulity and Delivery Systems (12 papers)Pharmaceutical studies and practices (10 papers)Safe Handling of Antineoplastic Drugs (9 papers)
Partner nations
United StatesAustria

In The Last Decade

Michael J. Akers

48 papers receiving 1.1k citations

Peers

Michael J. Akers
Comparison fields: 5 of 122
  • Molecular Biology 627
  • Pharmaceutical Science 344
  • Food Science 207
  • Materials Chemistry 183
  • Radiology, Nuclear Medicine and Imaging 150
Replace Dirk L. Teagarden with:
Dirk L. Teagarden United States
Weiguo Dai United States
M. Paloma Ballesteros Spain
Robert T. Forbes United Kingdom
Anna Millqvist‐Fureby Sweden
Masahiro Sakagami Japan
Chandan Bhugra United States
José B. Fariña Spain
Miguel Â. Rodrigues Portugal
Lee E. Kirsch United States
Michael J. Akers relative to Dirk L. Teagarden United States Dirk L. Teagarden's profile →
Citations per field
00.5×1.5×1.9×
Dirk L. Teagarden · 1×
Citations per year

Countries citing papers authored by Michael J. Akers

Since Specialization
Citations

This map shows the geographic impact of Michael J. Akers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Akers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Akers more than expected).

Fields of papers citing papers by Michael J. Akers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Akers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Akers. The network helps show where Michael J. Akers may publish in the future.

Co-authorship network of co-authors of Michael J. Akers

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Akers. A scholar is included among the top collaborators of Michael J. Akers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Akers. Michael J. Akers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3
BASICS OF STERILE COMPOUNDING: Sterilization Methods in Sterile Product Manufacturing.
1
4
Basic Principles of Lyophilization, Part 1.
1
5 96
6 7
7 64
8 71
9 20
10
Drying effects on residual moisture of lyophilization rubber closures.
1
11 48
12 153
13 17
14 31
15 225
16 80
17 3
18
Formulation design and development of parenteral suspensions.
28
19 15
20
F Value Requirements for the Destruction of Endotoxin in the Validation of Dry Heat Sterilization/Depyrogenation Cycles
1

About Michael J. Akers

Michael J. Akers is a scholar working on Occupational Therapy, Pharmaceutical Science and Microbiology, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (12 papers), Pharmaceutical studies and practices (10 papers) and Safe Handling of Antineoplastic Drugs (9 papers). The work is most often cited by research in Pharmaceutical Science (344 citations), Food Science (207 citations) and Occupational Therapy (43 citations). Michael J. Akers has collaborated with scholars based in United States and Austria. Frequent co-authors include Steven L. Nail, Lisa M. Hardwick, Stephanie A. Sweetana, Wei Y. Kuu, Gregory A. Sacha, Nathaniel Milton, Stephen R. Byrn, Mary P. Stickelmeyer, John L. Lach and L.J. Fischer. Their work appears in journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026